Abstract:Arteriosclerosis, Thrombosis, and Vascular Biology, Ahead of Print. BACKGROUND:Much of what we know about insulin resistance is based on studies from metabolically active tissues such as the liver, adipose tissue, and skeletal muscle. Emerging evidence suggests that the vascular endothelium plays a crucial role in systemic insulin resistance; however, the underlying mechanisms remain incompletely understood. Arf6 (ADP ribosylation factor 6) is a small GTPase that plays a critical role in endothelial cell function. Here, we tested the hypothesis that the deletion of endothelial Arf6 will result in systemic insulin resistance.METHODS:We used mouse models of constitutive endothelial cell–specific Arf6 deletion (Arf6f/−Tie2Cre) and tamoxifen-inducible Arf6 knockout (Arf6f/fCdh5CreER+). Endothelium-dependent vasodilation was assessed using pressure myography. Metabolic function was assessed using a battery of metabolic assessments including glucose and insulin tolerance tests and hyperinsulinemic-euglycemic clamps. We used a fluorescence microsphere–based technique to measure tissue blood flow. Skeletal muscle capillary density was assessed using intravital microscopy.RESULTS:Endothelial Arf6 deletion impaired insulin-stimulated vasodilation in white adipose tissue and skeletal muscle feed arteries. The impairment in vasodilation was primarily due to attenuated insulin-stimulated NO bioavailability but independent of altered acetylcholine-mediated or sodium nitroprusside–mediated vasodilation. Endothelial cell–specific deletion of Arf6 also resulted in systematic insulin resistance in normal chow–fed mice and glucose intolerance in high-fat diet–fed obese mice. The underlying mechanisms of glucose intolerance were reductions in insulin-stimulated blood flow and glucose uptake in the skeletal muscle and were independent of changes in capillary density or vascular permeability.CONCLUSIONS:Results from this study support the conclusion that endothelial Arf6 signaling is essential for maintaining insulin sensitivity. Reduced expression of endothelial Arf6 impairs insulin-mediated vasodilation and results in systemic insulin resistance. These results have therapeutic implications for diseases that are associated with endothelial cell dysfunction and insulin resistance such as diabetes.

Microvascular insulin resistance associates with enhanced muscle glucose disposal in CD36 deficiency

Microvascular insulin resistance with enhanced muscle glucose disposal in CD36 deficiency

Endothelial β1 Integrins are Necessary for Microvascular Function and Glucose Uptake

Loss of CD36 Impairs Hepatic Insulin Signaling by Enhancing the Interaction of PTP1B with IR.

Insulin Sensitivity Is Retained in Mice with Endothelial Loss of Carcinoembryonic Antigen Cell Adhesion Molecule 1

Endothelial-Specific Reduction in Arf6 Impairs Insulin-Stimulated Vasodilation and Skeletal Muscle Blood Flow Resulting in Systemic Insulin Resistance in Mice

Novel Paracrine Action of Endothelium Enhances Glucose Uptake in Muscle and Fat

Enhanced ECCD36 Signaling Promotes Skeletal Muscle Insulin Resistance in Female Mice

Endothelial metabolic control of insulin sensitivity through resident macrophages

Visceral obesity and insulin resistance associate with CD36 deletion in lymphatic endothelial cells

Insulin Resistance Is Associated With Reduced Capillary Permeability of Thigh Muscles in Patients With Type 2 Diabetes

CD44 contributes to hyaluronan-mediated insulin resistance in skeletal muscle of high-fat-fed C57BL/6 mice

CD36 as a target to prevent cardiac lipotoxicity and insulin resistance

Ubiquitinated CD36 sustains insulin-stimulated Akt activation by stabilizing insulin receptor substrate 1 in myotubes

Endothelial Notch signaling controls insulin transport in muscle

Inhibition of NFAT Signaling Restores Microvascular Endothelial Function in Diabetic Mice

Potential Protection Against Type 2 Diabetes in Obesity Through Lower CD36 Expression and Improved Exocytosis in β-Cells

CD36 deletion ameliorates diabetic kidney disease by restoring fatty acid oxidation and improving mitochondrial function

CD36 Protein Influences Myocardial Ca2+ Homeostasis and Phospholipid Metabolism

Effect of diabetes on hypoxic microvascular remodeling and muscle damage in chronic limb threatening ischemia